The trademark application LARIO THERAPEUTICS was filed by Lario Therapeutics Ltd, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on September 19, 2022, and it was registered by office on December 27, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations
Veterinary preparations
Chemical preparations for medical and pharmaceutical purposes
Pharmaceutical preparations for the treatment of neurological disorders
Pharmaceutical preparations for the treatment of central nervous system disorders
Pharmaceutical preparations for the treatment of neuro-degenerative diseases
Pharmaceutical preparations for the treatment of Parkinson's disease.
The mark was filed in class 42 with following description of goods:
Research, development, evaluation and design services in the fields of medical, biological, biotechnological, genetic, laboratory and pharmaceutical and veterinary preparations and medications
Research, development and design of drugs and medicine, veterinary preparations, laboratory and medical laboratory research and development services
Research, development, evaluation and design services in relation to neurological disorders
Research, development, evaluation and design services in relation to central nervous system disorders
Research, development, evaluation and design services in relation to neuro-degenerative diseases
Research, development, evaluation and design services in relation to Parkinson's Disease
Exploitation of scientific research and technology, preparation of reports
Development of prognostic and diagnostic tools
Consultancy and information services relating to all of the aforesaid.